Saladax

Saladax is a leader in the development of high quality diagnostic services and products, delivering actionable data to help physicians select and optimize the use of current and new pharmaceutical products to improve health and positively impact the economics of care. Saladax collaborates with pharmaceutical companies in the development of companion diagnostics, addressing risks and challenges encountered in drug development. Saladax is the global leader in diagnostics to optimize oncology drug dosing, with 15 drug-specific tests in the MyCare portfolio and over 80 worldwide patents issued.

www.saladax.com

Back to Companies

Kevin Harter
CEO
Companies